Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
P-glycoprotein 1 (P-gp) is an evolutionarily conserved transmembrane protein crucial for cellular defense against toxins but also responsible for clinically significant multidrug resistance due to its broad substrate specificity as an active efflux pump powered by ATP hydrolysis. It impacts both normal physiology—by protecting sensitive tissues—and pharmacology—by influencing how drugs are absorbed/distributed/metabolized/excreted/resisted throughout the body.
ATP-dependent efflux; actively pumps substrates out of cells against concentration gradients.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on P-glycoprotein 1 (P-gp).